Paper26940554
Azacitidine-Induced Pericarditis: A Case Series.
Newman M and 2 others. Pharmacotherapy, 2016. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Azacitidine-Induced Pericarditis: A Case Series. Papers, record 26940554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26940554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimetabolites, Antineoplastic | Major topic |
| Azacitidine | Major topic |
| DNA Modification Methylases | Major topic |
| Enzyme Inhibitors | Major topic |
| Pericarditis | Major topic |
| Aged | |
| Chest Pain | |
| Combined Modality Therapy | |
| Diagnosis, Differential | |
| Drug Monitoring | |
| Female | |
| Glucocorticoids | |
| Humans | |
| Leukemia, Myeloid, Acute | |
| Male | |
| Methylprednisolone | |
| Middle Aged | |
| Myelodysplastic Syndromes | |
| Prednisone | |
| Treatment Outcome |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42881025 | SOHO State of the Art Updates and Next Questions | The Evolving AML Treatment Paradigm. | Clin Lymphoma Myeloma Leuk | 2026 | https://conductscience.org/library/papers/42881025 | PubMed |
| 42424007 | Cardiotoxicity of Targeted Therapies in Hematologic Malignancies: From Molecular Mechanisms to Clinical Management. | Curr Treat Options Oncol | 2026 | https://conductscience.org/library/papers/42424007 | PubMed |
| 40176885 | The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40176885 | PubMed |
| 36355409 | A new software tool for computer assisted in vivo high-content analysis of transplanted fluorescent cells in intact zebrafish larvae. | Biol Open | 2022 | https://conductscience.org/library/papers/36355409 | PubMed |
| 36304621 | Azacitidine-induced myopericarditis in acute myeloid leukemia. | Proc (Bayl Univ Med Cent) | 2022 | https://conductscience.org/library/papers/36304621 | PubMed |
| 33324479 | Successful long-term treatment with azacitidine in patient with chronic myelomonocytic leukemia. | Hematol Rep | 2020 | https://conductscience.org/library/papers/33324479 | PubMed |
| 33322351 | Cardiotoxicity of Novel Targeted Hematological Therapies. | Life (Basel) | 2020 | https://conductscience.org/library/papers/33322351 | PubMed |
| 32620943 | Pharmacogenomics for immunotherapy and immune-related cardiotoxicity. | Hum Mol Genet | 2020 | https://conductscience.org/library/papers/32620943 | PubMed |
| 31912911 | Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase. | Br J Clin Pharmacol | 2020 | https://conductscience.org/library/papers/31912911 | PubMed |
| 30826891 | Cardiac Complications in the Adult Bone Marrow Transplant Patient. | Curr Oncol Rep | 2019 | https://conductscience.org/library/papers/30826891 | PubMed |
| 29315692 | Comprehensive review of cardiovascular toxicity of drugs and related agents. | Med Res Rev | 2018 | https://conductscience.org/library/papers/29315692 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26940554
GET https://conductscience.org/api/papers/v1/26940554/authors